| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |